Currently enrolling patients in Clinical Research Trials
To see if you are eligible, please call us at 913-871-1166.
5520 College Blvd., Suite 201
Overland Park, KS 66211 (map)
Phone: 913-871-1166
Fax: 913-491-9650
Blog
Stahl Leads Courses at National Physician Meeting
OVERLAND PARK, Kan (April 9, 2009) – Dr. Jason Stahl, Director of Refractive Lens Surgery at Durrie Vision, conducted two presentations at the American Society of Cataract and Refractive Surgeons held in San Francisco in April 2009. “Comparing Crystalens HD to other Presbyopia-correcting IOL combinations and Pseudophakic Monovision in Refractive Lens Exchange” was presented to refractive surgeons from around the country. He spoke about how to use different intra ocular lenses (IOLs) to improve both distant and near vision following refractive lens exchange. Clinical research data was presented to explain how each advanced IOL performs and how to choose the best IOL for individual patient needs.
The second presentation, “Quality of Life and Functional Status Assessment Following Implantation of AcrySof Phakic Angle Supported IOL,” highlighted the substantial reduction of dependence on corrective lenses, improved quality of life and functional status, and improved patient satisfaction of high myopia patients following implantation of the lens. Stahl is an investigator for the FDA Clinical trial Alcon AcrySof Phakic IOL used to treat myopia (nearsightedness).
